Abiopharma

🔍 Geffner Michael (Executive)

Company: Immunovant, Inc. (IMVT)

Report Date: 2025-10-22

Detailed Transactions and Holdings:

• Sold 2,595 shares of Common Stock at $19.03 per share (Direct)
  Date: 2025-10-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 217,958.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: On January 17, 2023, the holder was granted 100,000 restricted stock units ("RSUs"), as previously reported on a Form 3 filed on January 16, 2024, of which 6,250 of these RSUs vested on October 17, 2025. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
• F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.03 - $19.20 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.